IncellDx, MD Biosciences to Commercialize Coronavirus Cytokine Storm Test
IncellDx has been developing a test for cytokine storm-related cytokines, which it said are elevated in COVID-19 patients who experience long-term symptoms.
IncellDx, Factorial Diagnostics Ink Licensing, Supply Agreement
Factorial will use InCellDx's new IncellMax-Seq reagent to perform in situ library preparation for next-generation sequencing applications.
In Brief This Week: Hologic, Quidel, Illumina, Guardant Health, and More
News items for the in vitro diagnostics industry for the week of June 8, 2020.
Biolidics, IncellDx Sign Distribution Agreement
As part of the distribution agreement, Biolidics will distribute the IncellDx bioINK kit with Biolidics' ClearCell FX1 system.
IncellDx Inks Chinese Collaboration, Distribution Agreements
As part of the agreement, Kindstar will use InCellDx's single-cell immuno-oncology and oncology diagnostic products in China, including Hong Kong and Macao.
May 21, 2018
IncellDx Gets CE Mark for HPV Assay
Jan 17, 2018
IncellDx Inks Dx Distribution Deal in India
Oct 19, 2017